Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Where do they come up with all those goofy names for prescription drugs, anyway?

Doug Bremner, MD
Meds
February 22, 2024
Share
Tweet
Share

An excerpt from Pills, Shills, and the Psychiatry Wars: Musings from the Drug Safety & Healthcare News Blog.

I was spreading pine straw around the bushes in my yard in Atlanta, Georgia, when I started thinking about … you guessed it! The goofy names that drug companies come up with for their prescription drugs.

Folks in the blue states are often interested in the customs of us red state folks since they don’t get to read about them in the op-ed pages of papers like The New York Times (unless it is a scornful piece like the one about how the locals were rooting for abortion clinic bomber Eric Rudolph to get away … Run Rudolph Run!). Like when I wrote about the Georgia drought (“Drought and the Power of Prayer”), people thanked me for the update on what is going on down here.

Well, here is another interesting fascinoma (as we called it in med school). You see, most people think that the US is divided into red states and blue states. But within individual states there is also a division between red counties and blue counties.

In Georgia, the blue counties include Fulton and the other affluent areas in metropolitan Atlanta. The red counties are those below the so called “fault line” or “gnat line” in the southern half of the state. That is where the land is flat and the rivers run smoothly — or there are more gnats, take your pick.

And another interesting thing is that the red and blue parts are mutually interdependent. You see it is the job of the red parts to wander through the vast pine forests of South Georgia, gathering up pine needles and bundling them up so that they can ship them to Metro Atlanta (blue parts) where executives and professionals can take Saturdays off to buy the bundles of pine straw at the local garden center and dutifully spread it in their gardens. Nobody really knows why this ritual is necessary, but if the blue part people didn’t buy the pine straw, then the red part people might starve to death since there is no other industry in their area. And the red part people might rise up in revolution and cast out the blue part people farther north.

Anyway, the mandatory spreading of the pine straw that I share with my fellow Atlantans of the executive and professional classes is such a boring ritual that my mind naturally wandered. Who comes up with the names of prescription drugs anyway?

Take for example the drug Abilify (aripiprazole). An antipsychotic drug, the name is apparently meant to represent a new verb that will stimulate non-functioning mental patients to jump out of their chairs and start climbing the corporate ladder. Or how about that other anti-psychotic, Trilafon? The makers of this drug were obviously trying to suggest “try laughing.” Obviously, the manufacturers of this pill had never personally experienced the scary delusions or hallucinations that their pill was meant to treat, otherwise they would have never made such a zany suggestion. Here’s another one from the antipsychotic category: Mellaril. I suggest that the marketing people for that drug come up with a catchy tune with the words “Mellow out with Mellaril.” Maybe something from the Country and Western category?

Lest we think that goofy drug names are restricted to the anti-psychotic class (whose patrons might be thought to not be able to complain since they were, well … psychotic), let’s look at asthma drugs. Singulair is obviously meant to imply that you will only need to take one (single!) drug to get some… air. Well, Singulair may be making you want to go out and catch some air since it may be making you, well… nuts (see “If Don’t Kill Us They Will Drive Us Crazy”). Oh, one more from the asthma category: Serevent (salmeterol). This one is supposed to make us think of “breathing easy” (i.e., “SEREne VENTilation”). Kind of strange though for a drug that was described as causing patients to “die while clutching their inhalers.”

Hmmm. Not a very serene thought.

Doug Bremner is a psychiatrist and author of Pills, Shills, and the Psychiatry Wars: Musings from the Drug Safety & Healthcare News Blog.

Prev

How medical training indoctrinates toxic beliefs in physicians

February 22, 2024 Kevin 5
…
Next

Building expertise through collaboration [PODCAST]

February 22, 2024 Kevin 0
…

Tagged as: Medications

Post navigation

< Previous Post
How medical training indoctrinates toxic beliefs in physicians
Next Post >
Building expertise through collaboration [PODCAST]

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Doug Bremner, MD

  • The power of first impressions: How false information can stick

    Anne Bremner, JD & Doug Bremner, MD

Related Posts

  • Counterfeit drugs: a hidden danger lurking in your medicine cabinet

    Emily Kahoud
  • A Xanax prescription that should have been rejected

    Christy Huff, MD
  • Will Biden’s State of the Union remarks revive prescription drug reform?

    Hassaan Asif
  • The war on drugs: America’s secret racist war today

    Jay Wong
  • Inappropriate antibiotics are the new drugs of abuse

    Rosemary Eseh-Logue, MD
  • America’s prescription epidemic: Breaking an ancient promise

    Jesse Seilern und Aspang, MD, Riana Patel, MD and Mara Schenker, MD

More in Meds

  • Why retail pharmacies are the future of diverse clinical trials

    Shelli Pavone
  • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

    Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO
  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • First impressions happen online—not in your exam room

      Sara Meyer | Social media
    • How deep transcranial magnetic stimulation is transforming mental health care

      Muhamad Aly Rifai, MD | Conditions
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions
    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
  • Recent Posts

    • How deep transcranial magnetic stimulation is transforming mental health care

      Muhamad Aly Rifai, MD | Conditions
    • True stories of doctors reclaiming their humanity in a system that challenges it

      Alae Kawam, DO & Kim Downey, PT & Nicole Solomos, DO | Physician
    • How Gen Z is transforming mental health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Nurses aren’t eating their young — we’re starving the profession

      Adam J. Wickett, BSN, RN | Conditions
    • Why wanting more from your medical career is a sign of strength

      Maureen Gibbons, MD | Physician
    • U.S. health care leadership must prepare for policy-driven change

      Lee Scheinbart, MD | Policy

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why removing fluoride from water is a public health disaster

      Steven J. Katz, DDS | Conditions
    • When did we start treating our lives like trauma?

      Maureen Gibbons, MD | Physician
    • First impressions happen online—not in your exam room

      Sara Meyer | Social media
    • How deep transcranial magnetic stimulation is transforming mental health care

      Muhamad Aly Rifai, MD | Conditions
    • Dedicated hypermobility clinics can transform patient care

      Katharina Schwan, MPH | Conditions
    • Why ADHD in adults is often missed—and why it matters [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • Why tracking cognitive load could save doctors and patients

      Hiba Fatima Hamid | Education
    • What the world must learn from the life and death of Hind Rajab

      Saba Qaiser, RN | Conditions
    • The silent toll of ICE raids on U.S. patient care

      Carlin Lockwood | Policy
    • Why recovery after illness demands dignity, not suspicion

      Trisza Leann Ray, DO | Physician
    • Why does rifaximin cost 95 percent more in the U.S. than in Asia?

      Jai Kumar, MD, Brian Nohomovich, DO, PhD and Leonid Shamban, DO | Meds
    • Why medical students are trading empathy for publications

      Vijay Rajput, MD | Education
  • Recent Posts

    • How deep transcranial magnetic stimulation is transforming mental health care

      Muhamad Aly Rifai, MD | Conditions
    • True stories of doctors reclaiming their humanity in a system that challenges it

      Alae Kawam, DO & Kim Downey, PT & Nicole Solomos, DO | Physician
    • How Gen Z is transforming mental health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • Nurses aren’t eating their young — we’re starving the profession

      Adam J. Wickett, BSN, RN | Conditions
    • Why wanting more from your medical career is a sign of strength

      Maureen Gibbons, MD | Physician
    • U.S. health care leadership must prepare for policy-driven change

      Lee Scheinbart, MD | Policy

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...